Measles among adults, United States, 1985-1995

American Journal of Preventive Medicine

Volumn 17, Issue 2, 1999, Pages 114-119

  Miller, Mark ^a   Williams, Walter W ^b   Redd, Stephen C ^b  

^a Children's Vaccine Initiative   (Switzerland)

^b CENTERS FOR DIS CONTR AND PREV   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ADULT; ARTICLE; HUMAN; IMMUNIZATION; INCIDENCE; MEASLES; POLICY; UNITED STATES; VACCINATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HUMANS; INCIDENCE; MALE; MEASLES; MEASLES VACCINE; POPULATION SURVEILLANCE; RISK FACTORS; SEX DISTRIBUTION; UNITED STATES; VACCINATION;

EID: 0032872979     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-3797(99)00058-6     Document Type: Article

References (43)

1. Measles prevention. MMWR. 38:(Suppl 9):1989;1-18.
2. Measles prevention. MMWR. 36:1987;409-425.
3. Measles Surveillance - United States, 1991. MMWR. 41:(SS-6):1992;1-12.
4. Measles United States, 1997. MMWR. 47:(14):1998;273-276.
5. Hinman A.R., Brandling-Bennett D.B., Nieburg P.I. The opportunity and obligation to eliminate measles from the United States. JAMA. 242:(11):1979;1157-1162.
6. Sencer D.J., Dull H.B., Langmuir A.D. Epidemiologic basis for eradication of measles in 1967. Public Health Rep. 82:(3):1967;253-256.
7. Hopkins D.R., Hinman A.R., Koplan J.P., Lane J.M. The case for global measles eradication. Lancet. 1982;1396-1398.
8. Measles, Mumps and Rubella Vaccine Use and Strategies for Elimination of Measles, Rubella, and Congenital Rubella Syndrome and Control of Mumps Recommendations of the Advisory Committee on Immunization Practices (ACIP) . MMWR. 47:(RR-8):1998;1-57.
9. Update on adult immunization. MMWR. 40:(RR12):1991;1-94.
10. Chou T., Weil D., Arnow P. Prevalence of measles antibodies in hospital personnel. Infect Control. 7:(6):1986;309-311.
11. Braunstein H., Thomas S., Ito R. Immunity to measles in a large population of varying age. Am J Dis Child. 144:1990;296-298.
12. Kim M., LaPointe J., Liu F. Epidemiology of measles immunity in a population of healthcare workers. Infect Control Hosp Epidemiol. 13:(7):1992;399-402.
13. Watkins N.M., Smith R.P. Jr, St.Germain D.L., MacKay D.N. Measles (rubeola) infection in a hospital setting. Am J Infect Control. 15:1987;201-206.
14. Schwarcz S., McCaw B., Fukushima P. Prevalence of measles susceptibility in hospital staff evidence to support expanding the recommendations of the Immunization Practices Advisory Committee . Arch of Intern Med. 152:1992;1481-1483.
15. Subbarao E.K., Andrews-Mann L., Amin S., Greenberg J., Kumar M.L. Postexposure prophylaxis for measles in a neonatal intensive care unit. J Pediatr. 117:1990;782-785.
16. Wright L.J., Carlquist J.F. Measles immunity in employees of a multihospital healthcare provider. Infect Control Hosp Epidemiol. 15:1994;8-11.
17. Willy M.E., Koziol D.E., Fleisher T., et al. Measles immunity in a population of healthcare workers. Infect Control Hosp Epidemiol. 15:1994;12-17.
18. Smoak B.L., Novakoski L., Mason C.J., Erickson R.L. Evidence for a recent decrease in measles susceptibility among young American adults. J Infect Dis. 170:1994;216-219.
19. Albrecht P., Herrmann K., Bruns G.R. Role of virus strain unconventional and enhanced measles plaque neutralization test . J Virol Methods. 3:1981;251-260.
20. Chen R., Markowitz L.E., Albrecht P., et al. Measles antibody reevaluation of protective titers . J Infect Dis. 162:1990;1036-1042.
21. Markowitz L., Preblud S.R., Fine P.E., Orenstein W.A. Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J. 9:1990;101-110.
22. Christenson B., Bottiger M. Measles antibody comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus . Vaccine. 12:(2):1994;129-133.
23. Ratnam S., Veerabhadra G., West R., et al. Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody. J Clin Microbio. 33:(4):1995;811-815.
24. Schrag SJ, Glasser JW, Hutchins S, et al. Measles seroprevalence in the United States, 1957-1994. (In press).
25. National Center for Health Statistics. Health United States 1995. Hyattsville, Maryland: US Public Health Service; 1996.
26. Ramsay M.E., Moffatt D., O'Connor M. Measles vaccine a 27-year follow-up . Epidemiol Infect. 112:1994;409-412.
27. Miller C. Live measles vaccine a 21 year follow up . BMJ (Clin Res Ed). 295:1987;22-24.
28. abu Eldan J., Borcic B., Smerdel S. Persistence of immunity against measles in persons immunized with Edmonston-Zagreb vaccine. Acta Med Croatica. 45:1991;297-304.
29. Bolotovskii V.M., Gelikman B.G., Auzinia A.V., Glinskaia E.V. The duration and strength of postvaccinal measles immunity. Zh Mikrobiol Epidemiol Immunobiol. 1990;32-37.
30. Orenstein W.A., Markowitz L.E., Atkinson W.L., Hinman A.R. Worldwide measles prevention. Isr J Med Sci. 30:1994;469-481.
31. Hersh B.S., Markowitz L.E., Hoffman R.E., et al. A measles outbreak at a college with a prematriculation immunization requirement. Am J Public Health. 81:1991;360-364.
32. Cook L.G., Collins M., Williams W.W., Rodgers D., Baughman A.L. Prematriculation immunization requirements of American colleges and universities. J Am Coll Health. 42:1993;91-98.
33. Baughman A.L., Williams W.W., Atkinson W.L., Cook L.G., Collins M. The impact of college prematriculation immunization requirements on risk for measles outbreaks. JAMA. 272:1994;1127-1132.
34. Atkinson W.L., Markowitz L.E., Adams N.C., Seastrom G.R. Transmission of measles in medical settings - United States, 1985-1989. Am J Med. 91:1991;320S-324S.
35. Davis R.M., Orenstein W.A., Frank J.A. Jr, et al. Transmission of measles in medical settings. 1980 through 1984. JAMA. 255:1986;1295-1298.
36. Atkinson W.L. Measles and healthcare workers. Infec Control Hosp Epidemiol. 15:1994;5-7.
37. Vitek C.R., Hadler S.C., Redd S.B., Redd S.C. Trends in importation of measles to the United States, 1986-1994. JAMA. 277:(24):1997;1952-1956.
38. de Quadros C., Olive J.M., Hersh B.S., et al. Measles elimination in the Americas. JAMA. 275:1996;224-229.
39. Tulchinsky T.H., Ginsberg G.M., Abed Y., Angeles M.T., Akukwe C., Bonn J. Measles control in developing and developed countries the case for a two-dose policy . Bull World Health Organization. 71:1993;93-103.
40. Doshi SJ, Miller MA, Schultz LJ, Lobel HO. Vaccination rates among US travelers to developing countries, 1986-1991. Abstracts of the 124th Annual Meeting of the American Public Health Association, New York City, November, 1996.
41. Measles - United States, 1996, and the interruption of indigenous transmission. MMWR. 46:(11):1997;242-246.
42. Rota J.S., Rota P.A., Redd S.B., Redd S.C., Pattamadilok S., Bellini W.J. Genetic analysis of measles viruses isolated in the United States, 1995-1996. J Infect Dis. 177:(1):1998;204-208.
43. International importations of measles from the Americas into the United States, 1990-1994. EPI Newsletter. 17:1995;1-2.